Riggs Asset Management’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding VRNA
PCM
UOC
HI
FLSM
DKCM
GCL
NMC
Riggs Asset Management's VRNA Position: Q3 2025 in Review
Riggs Asset Management sold out of Verona Pharma (VRNA) in Q3 2025, closing a stake of 34 shares — an estimated $3.22K sold.
Riggs Asset Management first reported a position in VRNA in Q2 2025 and held it in 1 quarter. The position peaked at $3.22K in Q2 2025. 243 funds tracked by Wall St. Rank hold VRNA as of Q3 2025.
- Riggs Asset Management reported no remaining Verona Pharma position as of Q3 2025 after selling out during the quarter.
- Riggs Asset Management sold 34 Verona Pharma shares in Q3 2025, an estimated $3.22K.
- Riggs Asset Management first reported a position in Verona Pharma in Q2 2025 and held it in 1 quarter.
- Riggs Asset Management's Verona Pharma position peaked at $3.22K in Q2 2025.
- 243 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2025.
Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.